Lanka Hospitals launches ‘ZOE’ Priority Health at One Galle Face, Colombo

Thursday, 28 November 2019 02:43 -     - {{hitsCtrl.values.hits}}

Opening of ‘ZOE’ Priority Health at One Galle Face, Colombo


Lanka Hospitals, the internationally accredited, award-winning healthcare provider has launched ‘ZOE’ Priority Health at One Galle Face, Colombo. ZOE offers an enhanced patient experience with primary care services such as OPD/GP consultations, emergency care, specialist consultations, women’s and men’s wellness check-ups, life coaching and adolescent health, pharmaceuticals, laboratory and more.  

It also offers referral to high-end treatment facilities such as regenerative medicine and fertility services and a concierge service for local and international clientele. A dedicated medical team will be available for home visits to ensure efficient healthcare service delivery, for residents of nearby apartments and visitors of five-star hotels in the vicinity. 

“ZOE will provide urban residents and tourists alike, easy access to a multitude of health services close to their homes and offices at the heart of the city, saving travelling and waiting times. It is a service that will re-define health and wellness in Sri Lanka and help our visitors to enjoy benefits of health, at the highest level. Our facility comprises an ethical and value-based staff committed to offer quality health experience to serve with trust and care,” Lanka Hospitals Group Chief Executive Officer Dr. Prasad Medawatte stated.

Lanka Hospitals is the first hospital in Sri Lanka to be awarded some of the most prestigious accreditations in the world for its healthcare service standards including the Joint Commission International (JCI) accreditation since 2014, and the world-respected Medical Tourism Certification from the Medical Travel Quality Alliance (MTQUA). Furthermore, Lanka Hospitals Diagnostics (LHD) is the only Sri Lankan laboratory to be accredited by the prestigious laboratory accreditation body, The College of American Pathologists (CAP).